Archive Newsletter

1. 12.18.18 -- Cell & Gene's Best Of 2018
   12/18/2018
   12/18/18 Cell & Gene Newsletter
2. 12.13.18 -- Embracing Uncertainty By Bringing Optionality Into Facility And Capacity Planning
   12/13/2018
   12/13/18 Cell & Gene Newsletter
3. 12.11.18 -- The Status Of Regulatory Framework For Cell & Gene Therapies
   12/11/2018
   12/11/18 Cell & Gene Newsletter
4. 12.06.18 -- Cell & Gene's Best Of November
   12/6/2018
   12/06/18 Cell & Gene Newsletter
5. 12.04.18 -- 3 Keys To Establishing A Critical Supply Chain For Autologous C&G Therapies
   12/4/2018
   12/04/18 Cell & Gene Newsletter
6. 11.28.18 -- How Can Your Facility Benefit From Process Automation And Digitization?
   11/28/2018
   11/28/18 Cell & Gene Newsletter
7. 11.27.18 -- Inside A Patient's Pursuit To Join Penn's CAR-T Clinical Trial
   11/27/2018
   11/27/18 Cell & Gene Newsletter
8. 11.20.18 -- Novartis Turns To Digital Technologies For Clinical Trials
   11/20/2018
   11/20/18 Cell & Gene Newsletter
9. 11.13.18 -- 4 Commercialization Strategies For Gene And Cell Therapies
   11/13/2018
   11/13/18 Cell & Gene Newsletter
10. 11.06.18 -- ARM's CEO Recaps 2018 Meeting On The Mesa
    11/6/2018
    11/06/18 Cell & Gene Newsletter